1st Allergy and Clinical Research Group, d/b/a IMUNOe Research Centers

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Autism2 trials

Phase

• Phase 2/32 trials

Status

• Completed1 trial
• Terminated1 trial

Lead sponsor

• ACADIA Pharmaceuticals Inc.2 trials

Closed trials

• Terminated

  Extension Study of Pimavanserin in Irritability Associated With Autism Spectrum Disorder

  NCT05555615· Phase 2/3· ACADIA Pharmaceuticals Inc.· Source

• Completed

  Pimavanserin for the Treatment of Irritability Associated With Autism Spectrum Disorder

  NCT05523895· Phase 2/3· ACADIA Pharmaceuticals Inc.· Source